Event Brief
FDA Approves Leucovorin for Rare Cerebral Folate Deficiency
Filed: Mar 10, 2026 at 2:10 PM ET
Summary: The FDA has approved leucovorin calcium tablets for treating a rare neurological disorder, cerebral folate deficiency.
WHO: Food and Drug Administration
WHAT: Approved expanded use of leucovorin calcium tablets
WHEN: Mar 10, 2026 at 12:26 PM ET
WHERE: Location not specified
WHY: To treat cerebral folate deficiency, a rare neurological condition
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →